Related Articles
A mutation in the common docking domain of ERK2 in a human cancer cell line, which was associated with its constitutive phosphorylation
Characterization of a point mutation in the hormone binding domain of the estrogen receptor from an breast tumor.
Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells
Endogenous Leu332Gln mutation in p53 disrupts the tetramerization ability in a canine mammary gland tumor cell line
Genotype analysis of the NRF2 gene mutation in lung cancer